Related references
Note: Only part of the references are listed.Efficacy of long-term tenofovir disoproxil fumarate therapy in chronic hepatitis B patients with partial virologic response in real practice
Jeong Eun Song et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2019)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Involvement of multidrug resistance protein 4 in the hepatocyte efflux of lamivudine and entecavir
Yu-Tian Liu et al.
MOLECULAR MEDICINE REPORTS (2018)
Low-Level Viremia and the Increased Risk of Hepatocellular Carcinoma in Patients Receiving Entecavir Treatment
Jung Hee Kim et al.
HEPATOLOGY (2017)
Hepatitis B Cure: From Discovery to Regulatory Approval
Anna S. Lok et al.
HEPATOLOGY (2017)
Compartmental HBV evolution and replication in liver and extrahepatic sites after nucleos/tide analogue therapy in chronic hepatitis B carriers
Shan Gao et al.
JOURNAL OF CLINICAL VIROLOGY (2017)
Past, Current, and Future Developments of Therapeutic Agents for Treatment of Chronic Hepatitis B Virus Infection
Yameng Pei et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Clinical Course of Partial Virologic Response with Prolonged Tenofovir Therapy in Nuclos(t)ides-Na⟨ve Patients with Chronic Hepatitis B
In Du Jeong et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience
Grace C. Lovett et al.
WORLD JOURNAL OF HEPATOLOGY (2017)
AASLD guidelines for treatment of chronic hepatitis B
Norah A. Terrault et al.
HEPATOLOGY (2016)
Efficacy of interferon for chronic hepatitis B in patients with nucleoside and nucleotide combination therapy failure
Guo Qing Yin et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Tenofovir Alafenamide: A Review of Its Use in the Treatment of HIV-1 Infection
Amanda K. Gibson et al.
ANNALS OF PHARMACOTHERAPY (2016)
Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients during Pregnancy and Post-Partum Follow-Up
Boris Virine et al.
PLOS ONE (2015)
Efficacy of prolonged entecavir monotherapy in treatment-naive chronic hepatitis B patients exhibiting a partial virologic response to entecavir
Han Na Choi et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2015)
Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis
Roeland Zoutendijk et al.
GUT (2013)
MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0
Koichiro Tamura et al.
MOLECULAR BIOLOGY AND EVOLUTION (2013)
Efficacy of Entecavir With or Without Tenofovir Disoproxil Fumarate for Nucleos(t)ide-Naive Patients With Chronic Hepatitis B
Anna S. Lok et al.
GASTROENTEROLOGY (2012)
Evolutionary patterns of hepatitis B virus quasispecies under different selective pressures: correlation with antiviral efficacy
Feng Liu et al.
GUT (2011)
Entecavir Treatment for Chronic Hepatitis B: Adaptation Is Not Needed for the Majority of Naive Patients with a Partial Virological Response
Roeland Zoutendijk et al.
HEPATOLOGY (2011)
Efficacy and Safety of Entecavir Versus Adefovir in Chronic Hepatitis B Patients With Hepatic Decompensation: A Randomized, Open-Label Study
Yun-Fan Liaw et al.
HEPATOLOGY (2011)
Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy
C. S. Coffin et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Hepatitis B Virus Quasispecies in Hepatic and Extrahepatic Viral Reservoirs in Liver Transplant Recipients on Prophylactic Therapy
Carla S. Coffin et al.
LIVER TRANSPLANTATION (2011)
Entecavir Treatment for up to 5 Years in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Tenofovir Disoproxil Fumarate In Chronic Hepatitis B
Caroline M. Perry et al.
DRUGS (2009)
Entecavir shows limited efficacy in HBeAg-positive hepatitis B patients with a partial virologic response to adefovir therapy
Jurrien G. P. Reijnders et al.
JOURNAL OF HEPATOLOGY (2009)
Early changes of hepatitis B virus quasispecies during lamivudine treatment and the correlation with antiviral efficacy
Li Chen et al.
JOURNAL OF HEPATOLOGY (2009)
Entecavir: a step forward in combating hepatitis B disease
Cihan Yurdaydin
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Entecavir pharmacokinetics, safety, and tolerability after multiple ascending doses in healthy subjects
Jing-He Yan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
A review of entecavir in the treatment of chronic hepatitis B infection
A Rivkin
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Tenofovir disoproxil fumarate - Clinical pharmacology and pharmacokinetics
BP Kearney et al.
CLINICAL PHARMACOKINETICS (2004)
Share Paper
